Featured Posts
Blog
Congress considers micromanaging PBM finances
With the first reconciliation bill behind it, Congress is now looking to reform other aspects of the health care system. Pharmacy Benefit Manager (PBM)…
Blog
Free the Economy podcast: Drug costs and benefits with Sally Pipes
In this week’s episode we cover reforms to the Endangered Species Act, attacks on US tech firms, nuclear power innovation,…
National Review
Telehealth Is Less Promising Than It First Seemed
A key issue facing Congress in its postelection, “lame duck” session is whether to extend regulatory flexibilities expiring at year end that make telehealth services more…
Search Posts
Op-Eds
A Turkey of a Regulation
Corn — or maize as the Indians called it — has always been part of Thanksgiving tradition. But this year, many Americans have found that…
Citation
Our Phoniest Drug War
Op-Eds
Biotech Food Labeling is Regulatory Overkill: Henry Miller Op-Ed in LA Times
Published in the Los Angeles Times Published in the Los Angeles Times October 27, 2000 Headline: Biotech Food Labeling…
Op-Eds
Cracking Up Over Taco Shells; Why is the EPA Shelling Biotech Food? Henry Miller in Washington Times
Distributed nationally by Copley News Service Published in the Washington Times October 12, 2000 Kraft Foods has…
Op-Eds
A Much Higher Standard for Gene-Spliced Foods: Miller Op-Ed in SD Union-Tribune
Published in the San Diego Union-Tribune Published in the San Diego Union-Tribune October 5, 2000 Headline: A Much Higher…
Op-Eds
Effects of GM Confused with Those of Farming Practices: Conko Letter to Financial Times
Published in The Financial Times Published in The Financial Times September 6, 2000, Wednesday London Edition 1 …